Safety study of bretisilocin injection in healthy adults
This is an early-stage safety study testing how a new injection called bretisilocin moves through your body and what side effects it may cause. Researchers are enrolling healthy adults from different ethnic backgrounds to understand if the drug is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in good overall health with no serious medical conditions requiring ongoing treatment
- You have no history of seizures, epilepsy, or significant head trauma
- You have not used recreational drugs (ketamine, MDMA, cannabis, nitrous oxide) in the past 6 weeks
- You have no serious heart, metabolic, or mental health disorders
- You are willing to stay in a study facility for observation after receiving the injection
- Your heart rhythm (measured by ECG) and lab work are normal
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests how the body handles a new experimental drug called ABBV-1451, given as either an infusion (IV drip) or injection. Researchers want to make sure it's safe and well-tolerated in healthy volunteers before testing it in people with medical conditions.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This study tests a new drug called BIIB145 in healthy volunteers to see if it's safe and how the body handles it. It helps researchers learn about the drug before testing it in people with specific conditions.
This trial tests a new medicine, BW-50218, in healthy volunteers to see how safe it is and how the body processes it. If you are generally healthy and meet the specific requirements below, you may be able to help with early research on this potential treatment.
This is an early-stage safety test of a new injectable drug (SSS68) in healthy volunteers with no serious medical conditions. Researchers will give one dose under the skin and monitor how your body tolerates it over time.
This is an early-stage (Phase 1) safety test of a new investigational drug called BW-20805-2-1001 in people without serious health conditions. Researchers want to understand how the drug is tolerated and processed by the body when given as an injection.
Hear when a new Healthy Volunteer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.